Epigenetic Repression of by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP
As an inhibitor of cyclin-dependent kinases, p16INK4A is an important tumour suppressor and inducer of cellular senescence that is often inactivated during the development of cancer by promoter DNA methylation. Using newly established lymphoblastoid cell lines (LCLs) expressing a conditional EBNA3C from recombinant EBV, we demonstrate that EBNA3C inactivation initiates chromatin remodelling that resets the epigenetic status of p16INK4A to permit transcriptional activation: the polycomb-associated repressive H3K27me3 histone modification is substantially reduced, while the activation-related mark H3K4me3 is modestly increased. Activation of EBNA3C reverses the distribution of these epigenetic marks, represses p16INK4A transcription and allows proliferation. LCLs lacking EBNA3A express relatively high levels of p16INK4A and have a similar pattern of histone modifications on p16INK4A as produced by the inactivation of EBNA3C. Since binding to the co-repressor of transcription CtBP has been linked to the oncogenic activity of EBNA3A and EBNA3C, we established LCLs with recombinant viruses encoding EBNA3A- and/or EBNA3C-mutants that no longer bind CtBP. These novel LCLs have revealed that the chromatin remodelling and epigenetic repression of p16INK4A requires the interaction of both EBNA3A and EBNA3C with CtBP. The repression of p16INK4A by latent EBV will not only overcome senescence in infected B cells, but may also pave the way for p16INK4A DNA methylation during B cell lymphomagenesis.
Vyšlo v časopise:
Epigenetic Repression of by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000951
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000951
Souhrn
As an inhibitor of cyclin-dependent kinases, p16INK4A is an important tumour suppressor and inducer of cellular senescence that is often inactivated during the development of cancer by promoter DNA methylation. Using newly established lymphoblastoid cell lines (LCLs) expressing a conditional EBNA3C from recombinant EBV, we demonstrate that EBNA3C inactivation initiates chromatin remodelling that resets the epigenetic status of p16INK4A to permit transcriptional activation: the polycomb-associated repressive H3K27me3 histone modification is substantially reduced, while the activation-related mark H3K4me3 is modestly increased. Activation of EBNA3C reverses the distribution of these epigenetic marks, represses p16INK4A transcription and allows proliferation. LCLs lacking EBNA3A express relatively high levels of p16INK4A and have a similar pattern of histone modifications on p16INK4A as produced by the inactivation of EBNA3C. Since binding to the co-repressor of transcription CtBP has been linked to the oncogenic activity of EBNA3A and EBNA3C, we established LCLs with recombinant viruses encoding EBNA3A- and/or EBNA3C-mutants that no longer bind CtBP. These novel LCLs have revealed that the chromatin remodelling and epigenetic repression of p16INK4A requires the interaction of both EBNA3A and EBNA3C with CtBP. The repression of p16INK4A by latent EBV will not only overcome senescence in infected B cells, but may also pave the way for p16INK4A DNA methylation during B cell lymphomagenesis.
Zdroje
1. BornkammGW
HammerschmidtW
2001 Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356 437 459
2. Thorley-LawsonDA
GrossA
2004 Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas. The New England journal of medicine 350 1328 1337
3. RoughanJE
Thorley-LawsonDA
2009 The intersection of Epstein-Barr virus with the germinal center. J Virol 83 3968 3976
4. CrawfordDH
2001 Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356 461 473
5. TouitouR
O'NionsJ
HeaneyJ
AlldayMJ
2005 Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. J Gen Virol 86 1269 1277
6. TomkinsonB
RobertsonE
KieffE
1993 Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67 2014 2025
7. TomkinsonB
KieffE
1992 Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J Virol 66 2893 2903
8. HertleML
PoppC
PetermannS
MaierS
KremmerE
2009 Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathogens 5 e1000506
9. Le RouxA
KerdilesB
WallsD
DedieuJF
PerricaudetM
1994 The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205 596 602
10. WaltzerL
PerricaudetM
SergeantA
ManetE
1996 Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J Virol 70 5909 5915
11. RadkovSA
TouitouR
BrehmA
RoweM
WestM
1999 Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J Virol 73 5688 5697
12. CludtsI
FarrellPJ
1998 Multiple functions within the Epstein-Barr virus EBNA-3A protein. J Virol 72 1862 1869
13. BainM
WatsonRJ
FarrellPJ
AlldayMJ
1996 Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J Virol 70 2481 2489
14. BourillotPY
WaltzerL
SergeantA
ManetE
1998 Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. J Gen Virol 79 (Pt2) 363 370
15. KnightJS
LanK
SubramanianC
RobertsonES
2003 Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol 77 4261 4272
16. TouitouR
HickabottomM
ParkerG
CrookT
AlldayMJ
2001 Physical and Functional Interactions between the Corepressor CtBP and the Epstein-Barr Virus Nuclear Antigen EBNA3C. J Virol 75 7749 7755
17. HickabottomM
ParkerGA
FreemontP
CrookT
AlldayMJ
2002 Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J Biol Chem 277 47197 47204
18. ChinnaduraiG
2007 Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol 39 1593 1607
19. ShiY
SawadaJ
SuiG
Affar elB
WhetstineJR
2003 Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422 735 738
20. ShiY
LanF
MatsonC
MulliganP
WhetstineJR
2004 Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119 941 953
21. DahiyaA
WongS
GonzaloS
GavinM
DeanDC
2001 Linking the Rb and polycomb pathways. Mol Cell 8 557 569
22. MrozEA
BairdAH
MichaudWA
RoccoJW
2008 COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer Res 68 6049 6053
23. GilJ
PetersG
2006 Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7 667 677
24. ParkerGA
CrookT
BainM
SaraEA
FarrellPJ
1996 Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13 2541 2549
25. SerranoM
LinAW
McCurrachME
BeachD
LoweSW
1997 Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 593 602
26. ParkerGA
TouitouR
AlldayMJ
2000 Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis. Oncogene 19 700 709
27. ChoudhuriT
VermaSC
LanK
MurakamiM
RobertsonES
2007 The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block. J Virol 81 6718 6730
28. GruhneB
SompallaeR
MasucciMG
2009 Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene 28 3997 4008
29. KnightJS
RobertsonES
2004 Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity. J Virol 78 1981 1991
30. KnightJS
SharmaN
RobertsonES
2005 Epstein–Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci U S A 102 18562 18566
31. KnightJS
SharmaN
RobertsonES
2005 SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol Cell Biol 25 1749 1763
32. BajajBG
MurakamiM
CaiQ
VermaSC
LanK
2008 Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J Virol 82 4082 4090
33. SahaA
MurakamiM
KumarP
BajajB
SimsK
2009 Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J Virol 83 4652 4669
34. YiF
SahaA
MurakamiM
KumarP
KnightJS
2009 Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology 388 236 247
35. MaruoS
WuY
IshikawaS
KandaT
IwakiriD
2006 Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc Natl Acad Sci U S A 103 19500 19505
36. MaruoS
JohannsenE
IllanesD
CooperA
KieffE
2003 Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J Virol 77 10437 10447
37. AndertonE
YeeJ
SmithP
CrookT
WhiteRE
2008 Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27 421 433
38. PaschosK
SmithP
AndertonE
MiddeldorpJM
WhiteRE
2009 Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathogens 5 e1000492
39. SimonJA
KingstonRE
2009 Mechanisms of Polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10 697
40. BrackenAP
HelinK
2009 Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 9 773 784
41. DelecluseHJ
HilsendegenT
PichD
ZeidlerR
HammerschmidtW
1998 Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95 8245 8250
42. WhiteRE
CalderwoodMA
WhitehouseA
2003 Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. J Gen Virol 84 3393 3403
43. NeuhierlB
FeederleR
HammerschmidtW
DelecluseHJ
2002 Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A 99 15036 15041
44. KiaSK
GorskiMM
GiannakopoulosS
VerrijzerCP
2008 SWI/SNF Mediates Polycomb Eviction and Epigenetic Reprogramming of the INK4b-ARF-INK4a Locus. Mol Cell Biol 28 3457 3464
45. BarradasM
AndertonE
AcostaJC
LiS
BanitoA
2009 Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev 23 1177 1182
46. AggerK
CloosPA
RudkjaerL
WilliamsK
AndersenG
2009 The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 23 1171 1176
47. BernsteinBE
MikkelsenTS
XieX
KamalM
HuebertDJ
2006 A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 315 326
48. LukasJ
ParryD
AagaardL
MannDJ
BartkovaJ
1995 Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375 503 506
49. SewaltRG
GunsterMJ
van der VlagJ
SatijnDPE
OtteAP
1999 C-Terminal Binding Protein Is a Transcriptional Repressor That Interacts with a Specific Class of Vertebrate Polycomb Proteins. Mol Cell Biol 19 777 787
50. AtchisonL
GhiasA
WilkinsonF
BoniniN
AtchisonML
2003 Transcription factor YY1 functions as a PcG protein in vivo. EMBO Journal 22 1347 1358
51. SrinivasanL
AtchisonML
2004 YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev 18 2596 2601
52. LiH
ColladoM
VillasanteA
StratiK
OrtegaS
2009 The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460 1136 1139
53. KrivtsovAV
ArmstrongSA
2007 MLL translocations, histone modifications and leukaemia stem-cell development. Nature Rev Cancer 7 823 833
54. TiwariVK
McGarveyKM
LicchesiJD
OhmJE
HermanJG
2008 PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biology 6 2911 2927
55. MujtabaS
ManzurKL
GurnonJR
KangM
Van EttenJL
2008 Epigenetic transcriptional repression of cellular genes by a viral SET protein. Nat Cell Biol 10 1114 1122
56. YangX
HeZ
XinB
CaoL
2000 LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression. Oncogene 19 2002 2013
57. OhtaniN
BrennanP
GaubatzS
SanijE
HertzogP
2003 Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5. J Cell Biol 162 173 183
58. KeshetI
SchlesingerY
FarkashS
RandE
HechtM
2006 Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 38 149 153
59. SchlesingerY
StraussmanR
KeshetI
FarkashS
HechtM
2007 Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39 232 236
60. VireE
BrennerC
DeplusR
BlanchonL
FragaM
2006 The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439 871 874
61. OhmJE
McGarveyKM
YuX
ChengL
SchuebelKE
2007 A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39 237 242
62. WidschwendterM
FieglH
EgleD
Mueller-HolznerE
SpizzoG
2007 Epigenetic stem cell signature in cancer. Nat Genet 39 157 158
63. CedarH
BergmanY
2009 Linking DNA methylation and histone modification: patterns and paradigms. Nature Rev Genet 10 295 304
64. KlangbyU
OkanI
MagnussonKP
WendlandM
LindP
1998 p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 91 1680 1687
65. LindstromMS
WimanKG
2002 Role of genetic and epigenetic changes in Burkitt lymphoma. Semin Cancer Biol 12 381 387
66. Hernandez-MunozI
TaghaviP
KuijlC
NeefjesJ
van LohuizenM
2005 Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Mol Cell Biol 25 11047 11058
67. SchaeperU
BoydJM
VermaS
UhlmannE
SubramanianT
1995 Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A 92 10467 10471
68. BrownAC
BaigentSJ
SmithLP
ChattooJP
PetherbridgeLJ
2006 Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc Natl Acad Sci U S A 103 1687 1692
69. LeeS
SakakibaraS
MaruoS
ZhaoB
CalderwoodMA
2009 Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J Virol 83 12368 12377
70. MaruoS
WuY
ItoT
KandaT
KieffED
2009 Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc Natl Acad Sci U S A 106 4419 4424
71. HowleyPM
LivingstonDM
2009 Small DNA tumor viruses: large contributors to biomedical sciences. Virology 384 256 259
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 6
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requirement of NOX2 and Reactive Oxygen Species for Efficient RIG-I-Mediated Antiviral Response through Regulation of MAVS Expression
- Formation of Complexes at Plasmodesmata for Potyvirus Intercellular Movement Is Mediated by the Viral Protein P3N-PIPO
- Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
- Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection